Bloomios, Inc. (BLMS)
| Previous close | 0.0050 |
| Open | 0.0030 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0050 - 0.0050 |
| 52-week range | 0.0023 - 1.4000 |
| Volume | |
| Avg. volume | 405,811 |
| Market cap | 322,366 |
| Beta (5Y monthly) | 1.46 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.8600 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireBloomios Appoints Kevin Henry as National Sales Director
Bloomios, Inc. (OTCQB: BLMS), a leading innovator in contract manufacturing of hemp-derived cannabinoid & mushroom edibles, cosmetic & topical sports products, nootropics and adjacent wellness supplements, has appointed Kevin Henry to the new position of national sales director.
PR NewswireBloomios Reports Q1 2023 Revenue up 30% Sequentially and 84% Y/Y to $2.75 Million
Bloomios, Inc. (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, reported results for the first quarter ended March 31, 2023. All comparisons are to the same year-ago period unless otherwise noted.
- PR Newswire
Bloomios Appoints Industry Veteran, Joe Reid, as Chief Manufacturing Officer
Bloomios, Inc. (the "Company") (OTCQB: BLMS), a leading white-label and private-label manufacturer and wholesaler of hemp-derived nutraceutical, cosmetics and pet products, has appointed Upexi's former production division operations head, Joe Reid, as chief manufacturing officer of Bloomios' wholly owned subsidiary, Bloomios Private Label.
